Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Postpartum Depression Management Market Outlook (2022 to 2032)

The global postpartum depression management market is poised to register a 3.8% CAGR, capturing a revenue share of US$ 115.1 million in 2022, to reach US$ 173.9 million by 2032.

In pregnancy and childbirth, there is an acute case of clinical depression that is called postpartum depression. It is a very common mood disorder examined specifically in pregnant mothers, though it affects both men and women.

As per a study published in a peer-reviewed journal, 1 out of 7 women who gave birth to a newborn suffered from postpartum depression. After three weeks of giving birth to a newborn, a mother starts feeling the effects of depression. 

Postpartum depression management market growth is attributed to various factors that affect postpartum depression rates after pregnancy. These risk factors include hormonal and physical changes, a history of depression and stress, emotional imbalance, and bipolar disorder.

In pregnancy, mental disorders and mood swings are driving growth in the postpartum depression management market. Some of the major symptoms of postpartum depression among women include hopelessness, sadness, learning and memorizing, inability to focus, anxiety and exhaustion, loss of interest in self-care, and appetite problems.

Report Attribute Details
Postpartum Depression Management Market Value (2022) US$ 115.1 Million
Postpartum Depression Management Market Anticipated Forecast Value (2032) US$ 173.9 Million
Postpartum Depression Management Market Projected Growth Rate (2022 to 2032) 3.8%

To achieve better results, getting diagnosed by a doctor is crucial. Antidepressant prescriptions include Bupropion, Amitriptyline, Trimipramine, Fluoxetine, Paroxetine, Fluoxetine, Fluoxetine, Fluoxetine, Fluoxetine, and others. In contrast, counseling involves talk therapy with therapists or psychologists who provide management tips to help combat the conditions.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Management Market Dynamics Postpartum Depression?

The growing demand for antidepressant drugs and talk therapies by expectant pregnant mothers is projecting the growth of the postpartum depression management market. Therefore, spending on postpartum depression management is increasing over time.

The postpartum depression management market is growing worldwide as women across the globe are lately experiencing postpartum depression as they find it difficult to cope with new responsibilities. The postpartum depression management market includes various home remedies that involve maintaining healthy lifestyle choices, avoiding isolation, to set realistic expectations.

Based on treatment type, anti-depressants are the most commonly used treatment methods over therapies as anti-depressants provide fast treatment and promising results in less time as compared with psychotherapies.

The anti-depressants treatment segment thus accounts for the largest revenue share in the postpartum depression management market. The segment is anticipated to follow the same trend in the postpartum depression management market over the next few years. As a result, women prefer it over psychotherapies to achieve faster results.

Some of the key factors driving the growth of the postpartum depression management market include the rise in risk factors associated with postpartum depression. These include the growing preference of women for the treatment of postpartum depression.

Women have become more aware of postpartum depression management and are more inclined to seek early treatment and therapies, which is further driving the global market for postpartum depression management.

It is expected that postpartum depression management market growth will be constrained by negligence and unacceptance of the condition, along with an inability to detect depression.

Regional Analysis

How is the North America Postpartum Depression Management Market Evolving?

The demand for postpartum depression management has increased in the North American region. North America is anticipated to control a postpartum depression management market share of 37.5% in 2022.

In the last decade, North America has held the largest revenue share in the global postpartum depression management market on account of rising awareness among women regarding postpartum depression. It also enhanced decision-making by women with high educational attainment and easy availability of psychotherapy sessions with specialized doctors.

What is the Growth Outlook for the Europe Postpartum Depression Management Market?

Europe's Postpartum Depression Management is predicted to experience significant growth and hold a market share of 29% in 2022. Mental health awareness is increasing among individuals and major companies are investing in countries in this region, which is driving revenues in the Europe postpartum depression market.

The market for postpartum depression in Europe is expected to be driven by an increasing number of initiatives to treat postpartum depression through telemedicine virtual support over calls and online counseling, as well as an increasing number of support groups and mental health communities for mothers.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Start-up Ecosystem

How is the Start-up Ecosystem in the Postpartum Depression Management Market?

The start-up ecosystem in the postpartum depression management market is clouded by several pharmaceutical companies, including Marinus Pharma and others, who are actively developing therapies to grow the postpartum depression management market share. In addition, they manufacture novel therapies to transform the treatment paradigm of the postpartum depression management market.

Sage Therapeutics and Marinus Pharmaceuticals are two major players developing therapies for postpartum depression (PPD). There will be a significant impact on the postpartum depression (PPD) market from the launch of new therapies such as SAGE-217 and Ganaxolone.

  • The American biopharmaceutical firm Sage Therapeutics, which developed Zuranolone with Biogen Inc., announced on 1 June 2022 that it had achieved all primary and secondary endpoints in its Phase 3 SKYLARK study.

How is Competition Landscape in the Postpartum Depression Management Market?

The postpartum depression management market is consolidated with a presence of a few strong players from around the globe. Some of the key players present in the global postpartum depression management market are Sage Therapeutics Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Anikem Laboratories, Intas Pharmaceuticals Ltd., Mylan N.V., Sumika Fine Chemicals Co Ltd., and others.

emerging trends in the postpartum depression management market are brought about as a result of the major players' adoption of several growth strategies, including product launches, acquisitions, and collaborations.

Some of the recent developments in the Postpartum Depression Management market are as follows:

  • A leading player among two prominent emerging players is Sage Therapeutics with its drug prospect SAGE-217 which has been shown in clinical trials to show promise in battling postpartum depression.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Report Scope

Report Attribute Details
Growth Rate CAGR of 3.8% from 2022 to 2032
Base Year for Estimation 2022
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Treatment Type
  • Distribution Channel
  • Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • The Asia Pacific excluding Japan
  • Japan
  • The Middle East and Africa
Key Countries Profiled
  • The USA
  • Canada
  • Brazil
  • Argentina
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • GCC Countries
  • South Africa
Key Companies Profiled
  • Sage Therapeutics Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Anikem Laboratories
  • Intas Pharmaceuticals Ltd.
  • Mylan N.V.
  • Sumika Fine Chemicals Co Ltd.
Customization Available Upon Request

Key Segments

By Treatment Type:

  • Anti-Depressant Drugs
  • Bupropion
  • Fluoxetine
  • Doxepin
  • Others

By Distribution Channel:

  • Hospital
  • Retail
  • Drug Stores
  • E-Commerce

By Region:

  • North America
  • Latin America
  • Middle East and Africa
  • Europe
  • Asia Pacific

Frequently Asked Questions

What is the Future of the Postpartum Depression Management Market?

The postpartum depression management market is likely to account for US$ 173.9 million by 2032.

What is the Anticipated Postpartum Depression Management Market Share of North America?

North America is likely to hold a postpartum depression management market share of 37.5% in 2022.

What is the Growth Outlook for the Postpartum Depression Management Market?

The global postpartum depression management market is set to advance at a CAGR of 3.8% from 2022 to 2032.

What is the Size of Postpartum Depression Management?

The postpartum depression management market is projected to grow to US$ 115.1 million in 2022.

Table of Content

1. Executive Summary | Postpartum Depression Management Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Treatment

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2022 to 2032

        5.3.1. Anti-Depressant Drugs

        5.3.2. New Anti-Depressant Drugs

        5.3.3. SAGE-547

        5.3.4. Bupropion

        5.3.5. Escitalopram

        5.3.6. Fluoxetine

        5.3.7. Paroxetine

        5.3.8. Sertraline

        5.3.9. Old Anti-Depressant Drugs

        5.3.10. Amitriptyline

        5.3.11. Desipramine

        5.3.12. Others

    5.4. Y-o-Y Growth Trend Analysis By Treatment, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Treatment, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032

        6.3.1. Hospital Pharmacies

        6.3.2. Retail Pharmacies

        6.3.3. Drug Stores

        6.3.4. E-commerce

    6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. United States of America

            8.2.1.2. Canada

        8.2.2. By Treatment

        8.2.3. By Distribution Channel

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Treatment

        8.3.3. By Distribution Channel

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Treatment

        9.2.3. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Treatment

        9.3.3. By Distribution Channel

    9.4. Key Takeaways

10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Treatment

        10.2.3. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Treatment

        10.3.3. By Distribution Channel

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. India

            11.2.1.5. Malaysia

            11.2.1.6. Singapore

            11.2.1.7. Australia

            11.2.1.8. New Zealand

            11.2.1.9. Rest of Asia-Pacific

        11.2.2. By Treatment

        11.2.3. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Treatment

        11.3.3. By Distribution Channel

    11.4. Key Takeaways

12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of Middle East and Africa

        12.2.2. By Treatment

        12.2.3. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Treatment

        12.3.3. By Distribution Channel

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. United States of America

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Treatment

            13.1.2.2. By Distribution Channel

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Treatment

            13.2.2.2. By Distribution Channel

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Treatment

            13.3.2.2. By Distribution Channel

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Treatment

            13.4.2.2. By Distribution Channel

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Treatment

            13.5.2.2. By Distribution Channel

    13.6. United Kingdom

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Treatment

            13.6.2.2. By Distribution Channel

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Treatment

            13.7.2.2. By Distribution Channel

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Treatment

            13.8.2.2. By Distribution Channel

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Treatment

            13.9.2.2. By Distribution Channel

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Treatment

            13.10.2.2. By Distribution Channel

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Treatment

            13.11.2.2. By Distribution Channel

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Treatment

            13.12.2.2. By Distribution Channel

    13.13. Malaysia

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Treatment

            13.13.2.2. By Distribution Channel

    13.14. Singapore

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Treatment

            13.14.2.2. By Distribution Channel

    13.15. Australia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Treatment

            13.15.2.2. By Distribution Channel

    13.16. New Zealand

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Treatment

            13.16.2.2. By Distribution Channel

    13.17. GCC Countries

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Treatment

            13.17.2.2. By Distribution Channel

    13.18. South Africa

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Treatment

            13.18.2.2. By Distribution Channel

    13.19. Israel

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Treatment

            13.19.2.2. By Distribution Channel

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Treatment

        14.3.3. By Distribution Channel

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. SAGE Therapeutics Inc.

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Cipla Limited

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Sun Pharmaceutical Industries Ltd.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Anikem Laboratories

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Intas Pharmaceuticals Ltd.

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Mylan N.V.

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Sumika Fine Chemicals Co Ltd.

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Aurobindo Pharma

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Lupin

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Accord Healthcare

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Recommendations

Healthcare

Depression Treatment Market

Published : May 2022

Healthcare

Drug Free Depression Treatment Market

Published : April 2022

Explore Healthcare Insights

View Reports

Postpartum Depression Management Market